Logo
Close
Your free order overview
    You currently have not items to display
Logo
Close
Your contact details
Title
Gender
First Name*
Last Name*
Email*
Telephone
Country
Street
Number (+ Bus)
City
Postal code

* required fields

Logo
Close
Order completed!

Thank you

Thank you for choosing Janssen Medical Cloud for ordering your materials.

Message from Darzalex team

Message from Darzalex team
It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.
Manage cookie settings

References

  • One-Year Update of a Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Patients (Pts) with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): Alcyone https://doi.org/10.1182/blood-2018-156
  • AcasterS, et al. Support Care Cancer. 2013:21:599-607.
dara_new-logo

CP-145523

© Janssen Pharmaceutica NV 2021. This site is published by Janssen Pharmaceutica NV which is solely responsible for its content. It is intended for European, Middle Eastern and African Healthcare professionals.
Cookie PolicyPrivacy PolicyLegal Notice
Cookie Settings
Logo